GRALVSNIVF• 12 Months (Normalized)
GRAL vs NIVF (GRAIL Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GRAL Performance $136.57
+130.97%
GRAIL Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
+%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin GRAL LEADS
+130.97 pts
GRAL outperforming by 130.97 percentage points
GRALNIVF
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GRAL NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | GRAL Price | GRAL Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $136.57 | +130.97% | $- | - | |
| Sep 28, 2026 | $132.63 | +124.30% | $- | - | |
| Sep 25, 2026 | $126.89 | +114.59% | $- | - | |
| Sep 24, 2026 | $125.21 | +111.75% | $- | - | |
| Sep 23, 2026 | $108.52 | +83.53% | $0.59 | -99.94% | +183.47% |
| Sep 22, 2026 | $108.52 | +83.53% | $0.73 | -99.92% | +183.45% |
| Sep 21, 2026 | $107.97 | +82.60% | $0.72 | -99.93% | +182.53% |
| Sep 18, 2026 | $80.77 | +36.60% | $0.72 | -99.93% | +136.53% |
| Sep 17, 2026 | $79.95 | +35.21% | $0.72 | -99.93% | +135.14% |
| Sep 16, 2026 | $75.11 | +27.03% | $0.79 | -99.92% | +126.95% |
| Sep 15, 2026 | $75.89 | +28.34% | $0.84 | -99.91% | +128.25% |
| Sep 14, 2026 | $75.53 | +27.74% | $0.93 | -99.90% | +127.64% |
| Sep 11, 2026 | $76.23 | +28.92% | $1.06 | -99.89% | +128.81% |
| Sep 10, 2026 | $77.56 | +31.17% | $1.11 | -99.89% | +131.06% |
| Sep 09, 2026 | $77.48 | +31.03% | $1.10 | -99.89% | +130.92% |
Page 1 of 17